A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT06256523 · COMPLETED
Trial details
- NCT number
- NCT06256523
- Sponsor
- Gan and Lee Pharmaceuticals, USA
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-29
- Primary completion
- 2023-09-28
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.